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Abstract Publication ethics is an important aspect of both the research and
publication enterprises. It is particularly important in the field of biomedical science
because published data may directly affect human health. In this article, we examine
publication ethics policies in biomedical journals published in Central and Eastern
Europe. We were interested in possible differences between East European coun-
tries that are members of the European Union (Eastern EU) and South-East Euro-
pean countries (South-East Europe) that are not members of the European Union.
The most common ethical issues addressed by all journals in the region were
redundant publication, peer review process, and copyright or licensing details.
Image manipulation, editors’ conflicts of interest and registration of clinical trials
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were the least common ethical policies. Three aspects were significantly more
common in journals published outside the EU: statements on the endorsement of
international editorial standards, contributorship policy, and image manipulation.
On the other hand, copyright or licensing information were more prevalent in
journals published in the Eastern EU. The existence of significant differences among
biomedical journals’ ethical policies calls for further research and active measures
to harmonize policies across journals.
Keywords Publication ethics  Ethical criteria  Central and Eastern Europe 
Research ethics
Background
In this article, publication ethics is understood as ‘‘a set of principles and the rules
derived from them (some of the rules unwritten) that describe the proper behavior
of authors, editors, reviewers, publishers, and academic and research institutions
according to today’s standards’’ (Caelleigh 2003). Publication ethics is an emerging
topic in the scientific and publishing community. Many professional organizations
have promulgated ethics guidelines for publications (Bošnjak and Marušic 2012).
Editors and publishers’ organizations, such as the Committee on Publication Ethics
(COPE) (COPE 2012), have been established specifically to address ethical issues
emerging in the publishing process (COPE 2009).
Well–publicized scandals involving scientific misconduct (Kim and Park 2012;
Sokal 1996) may drive editors, publishers and ethicists to continually improve
publication ethics policies. On the other hand, surveys have shown a lack of concern
by editors for such issues and a common belief that misconduct occurs only rarely in
their journals (Wager et al. 2009). Other surveys have demonstrated great variability
in journals’ conflict of interest forms, as well as differences in practices in asking for
conflict of interest declarations from authors, reviewers and editors (Cooper et al.
2006). Although scientific journals have an important role in protecting research
integrity, they can only deal with the publication end of the research process; other
stakeholders in the research enterprise have an even more important role in fostering
the responsible conduct of research (Marušić and Marušić 2006; Marušić et al.
2007), including training in research and publication ethics (Kim et al. 2008).
Publication ethics in the field of biomedical science is particularly important
because published data may directly affect human health. Publication standards in
biomedicine are addressed not only by general editorial associations, such as the
Committee on Publication Ethics (COPE), but also by specialized medical editorial
organizations, such as the World Association of Medical Editors (WAME) and the
International Committee of Medical Journal Editors (ICMJE). The biomedical
research community also has a strong research activity in this field, best illustrated
by the Peer Review Congress organized by JAMA and the BMJ Group. General
international ethics documents devoted to biomedical research also focus on the
issue of publication responsibility. Article 30 of the latest version of the WMA
Declaration of Helsinki (2008) states that ‘‘Authors, editors and publishers all have
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ethical obligations with regard to the publication of the results of research. […].
Sources of funding, institutional affiliations and conflicts of interest should be
declared in the publication’’. This very influential international instrument
reinforces the importance of publication ethics.
The aim of our research was to examine ethics policies of biomedical journals
published in Central and Eastern Europe (CEE). We were interested in this region
for several reasons. The countries in the region have evolved from similar
‘‘communist’’ roots and all are societies in rapid socioeconomic transition. Most
have adopted international regulations, including those covering biomedical
research. CEE countries constitute an attractive market for international clinical
trials. However, ethical standards in the field of biomedicine are still problematic in
these countries (Dranseika et al. 2011; Famenka 2011; Gefenas et al. 2010; Silis
2010; Waligora 2012).
We were interested in possible differences between East European countries that
are members of the European Union (Eastern EU) and South-East European
countries (South-East Europe) that are not members of the European Union. The
underlying hypothesis was that the countries that have already joined the EU would
have more advanced ethical requirements because of the required harmonization of
their legal systems with the European Union, including the regulation of clinical
trials and research on humans (Marušić 2005). We expected that biomedical
journals from EU member post-communist countries would also revise their policies
to reflect new regulations faster than post-communist countries outside the EU.
Methods
We identified biomedical journals from two groups of countries: (1) East European
countries within the European Union (Eastern EU): Czech Republic, Hungary,
Romania, Bulgaria, Slovenia, Slovakia, Poland, Lithuania, Latvia, Estonia; and (2)
South-East European countries (South-East Europe) that are not members of the
European Union: Bosnia and Herzegovina, Serbia, Montenegro, Croatia, Macedo-
nia, Albania; Greece was excluded from the study because it is a member of
European Union but geographically belongs to South-East Europe.
Biomedical journals from these countries were identified using PubMed in March
2011. Search limits were set to include journals according to the country of issue,
publication in English, and MEDLINE indexing. For each journal, instructions for
authors were retrieved from their web pages.
The instructions for authors of these journals were then subjected to content
analysis for ethics policy content (Table 1). We created a list of the most important
ethical themes based on a checklist from the International Network for the
Availability of Scientific Publications (INASP) and guidelines for ethical publica-
tion from ICMJE, WAME and COPE. The checklist had previously been used to
assess publication practices of biomedical journals from the Eastern Mediterranean
Region of the World Health Organization (Utrobičić et al. 2012).
The policies were not listed in order of importance but represented a list of
publication ethics policies relevant to biomedical journals.
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Results were expressed as percentages for categorical variables or mean ± SD
for continuous variables. Differences were tested using v2-test or Student t test,
respectively. MedCalc version 11.5.1 was used for analysis (MedCalc, Mariakerke,
Belgium).
Results
We identified 62 journals in Eastern EU, from which we could retrieve 57 (92 %) of
the instructions for authors. Out of 12 journals identified in South-East Europe, 11
(92 %) had publicly available instructions for authors.
Table 1 Definitions of ethical policies
Ethical policy Definition present in guidelines for authors
Endorsement of international editorial
standards
Explicit statement of the journal’s conformance with
international editorial standards
Peer review process General information on the process of evaluating
manuscripts and a summary of the peer review process
Redundant publication Policy on article submissions in print or electronic media
(issues such as republications, duplicate publication,
self-plagiarism, dual submission, etc.) and policy on
how such occurrences are handled
Authorship policy Policy/definition of authorship (including ethical position
on ghost and gift authorship)
Contributorship policy Clear rules on the declaration of contributorship of each
co-author
Conflicts of interest Disclosure policy of financial and personal relationships
that could inappropriately influence (bias) actions
Requirements on disclosure of sources of
financial support
Statement in the journal instructions about institutions
and grants supporting the publication
Requirements on ethical conduct of
biomedical research with human subjects
Statement of ethical biomedical research with human
subjects
Requirements on ethical conduct of
biomedical research with non-human
subjects
Statement of ethical biomedical research with non-
human subjects
Ethical review by institutional review board Statement that submitted articles have to state whether
the study received approval from a relevant ethics
committee
Mandatory registration of clinical trials Statement on mandatory registration of clinical trials
Privacy rights and confidentiality statements Policy on proper use of personal identifiable information
Copyright or license-to-publish Instructions regarding assignment of copyright or
license-to-publish
Image manipulation Instructions and requirements regarding processing
digital images and policy for addressing image
manipulation
Conflicts of editors as authors in own
journals
Policy on how the journal manages research in which the
editor is an author
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The mean number of publication ethics policies was 5.2 ± 3.2 in journals
published in EU countries and 6.6 ± 3.7 (P = 0.176, t test) in journals published
outside the EU.
We identified significant differences in the presence of publication ethics policies
in journals from EU and non-EU CEE countries (Table 2). The following policies
were significantly more prevalent in journals published in the countries outside EU:
statements on endorsement of international publishing or editorial standards
(v2 = 18.90, P \ 0.001), contributorship policy (v2 = 8.06, P = 0.005) and image
manipulation (v2 = 10.70, P = 0.001). Copyright or license-to-publish policies
were more prevalent in journals published in the EU CEE countries (v2 = 5.39,
P = 0.020).
Table 2 Prevalence of ethics policies in Eastern EU (n = 57) and South-East Europe (n = 11)
Ethics policy Journals from
Eastern EU
(%)
Journals from
South-East Europe
(%)
Chi square,
P
Endorsement of international standards 10 (18 %) 9 (82 %) 18.90,
P \ 0.001
Description of process of manuscript
evaluation
43 (75 %) 9 (82 %) 0.209,
P = 0.648
Redundant publication 43 (75 %) 7 (64 %) 0.660,
P = 0.417
Authorship policy 23 (40 %) 7 (64 %) 2.03,
P = 0.154
Contributorship policy 9 (16 %) 6 (55 %) 8.06,
P = 0.005
Conflicts of interest 21 (37 %) 6 (55 %) 1.21,
P = 0.272
Requirements on disclosure of sources
of financial support
16 (28 %) 4 (36 %) 0.305,
P = 0.580
Requirements on ethical conduct of
biomedical research with human subjects
26 (46 %) 8 (73 %) 2.71,
P = 0.100
Requirements on ethical conduct
of biomedical research with non-human
subjects
27 (47 %) 3 (27 %) 1.51,
P = 0.219
Ethical review by institutional review board 25 (44 %) 3 (27 %) 1.05,
P = 0.306
Mandatory registration of clinical trials 1 (2 %) 1 (9 %) 1.74,
P = 0.187
Privacy rights and confidentiality statements 11 (19 %) 5 (45 %) 3.51,
P = 0.061
Copyright or license-to-publish 37 (65 %) 3 (27 %) 5.39,
P = 0.020
Image manipulation 0 (0 %) 2 (18 %) 10.70,
P = 0.001
Conflicts of editors as authors in own journals 1 (2 %) 1 (9 %) 1.74,
P = 0.187
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The issues most frequently addressed in Eastern EU journals were copyright and
licensing (37/57 journals, 65 %), peer review process (43/57 journals, 75 %), and
redundant publication (43/57 journals, 75 %). In journals from South-East Europe,
the most frequent policies were on ethical conduct in clinical research (8/11 journals,
73 %), process of evaluating manuscripts and peer review process (9/11, 82 %), and
statements on conformance with international editorial standards (9/11 journals,
82 %) (Table 2).
The issues least frequently addressed in Eastern EU journals were image
manipulation (0/57 journals, 0 %), editors’ conflicts of interests (when editor is an
author) (1/57 journals, 2 %), and registration of clinical trials (1/57 journals, 2 %).
In the South-East European journals these were editors’ conflicts of interest
(1/11 journals, 9 %), registration of clinical trials (1/11 journals, 9 %) and image
manipulation (2/11 journals, 18 %) (Table 2).
Discussion
Our study demonstrated significant differences in the prevalence of publication
ethics policies between journals from Eastern EU and South-East Europe. Three
publication ethics policies were more frequently adopted by journals published in
CEE countries outside the EU: (1) statement of the journal’s conformance with
international editorial standards; (2) contributorship policy, defined as ‘‘Declaration
of exact contributions of each co-author, preferably in the following categories:
(a) study design: (b) data collection: (c) statistical analysis: (d) literature search:
(e) acquisition of funding’’, and (3) image manipulation, defined as ‘‘Instructions
and requirements regarding processing digital images and policy for addressing
image manipulation’’. The policy most often found in journals from East EU
countries was copyright or license-to-publish, defined as ‘‘Instructions regarding
assignment of copyright or license-to-publish’’.
There may be several possible explanations for the study findings. It is possible that
editors in the South-East European countries have had more editorial training or
expertise, which is reflected in their journals’ policies. A recent study of Italian
biomedical journals (Matarese 2008) showed that editorial leadership predicted the
quality of journals, including the presence of publication ethics policies. As the public
information we had available for the study did not differentiate between more
professional or commercial journals and small scholarly journals, we could not relate
the extent of such professionalism with the presence of ethics policies. It is also
possible that journals from non-EU countries are more keen on improving their
visibility in the mainstream scientific community and thus more motivated to follow
developments in editorial policies and be quicker in their implementation. Further-
more, it is possible that older journals that have an established readership and visibility
may pay more attention to editorial standards in general and publication ethics policies
in particular. As for the difference in the prevalence of copyright or license-to-publish
policies, it is possible that intellectual property rights are more respected in the EU and
the journals have a legal duty to establish clear rules for publication. Another reason
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might be that journals in the EU countries are more concerned with the commercial
aspects of publication than its ethical aspects.
In our literature search of PubMed we could not identify similar studies
comparing formal ethical requirements among biomedical journals in countries
undergoing socioeconomic transition in the same geographical region but under
different sociopolitical influences. Therefore, it is not clear how generalizable our
findings may be. Methodologically robust studies are needed to address the
observed differences between countries in more detail.
Our study indicates that the least frequently addressed policies for both regions
were image manipulation, conflicts arising when editors act as authors in their own
journals and mandatory registration of clinical trials. A possible reason for the low
prevalence of policies on image manipulation could be that most of the journals we
studied were either general medical journals or journals that did not publish many
articles with digital images, unlike natural science or basic biomedical research
journals which originally developed the policy (Rossner and Yamada 2004). The
low prevalence of the ‘‘Editor as an author’’ policies may be related to a lack of
concern on the part of editors about their own possible conflicts of interest. Editors
are usually the authors of a journals’ instructions but appear to apply them only to
other authors and not to themselves. Other studies have also demonstrated that
journals had an unequal application of conflict of interest policies, with authors
being required to follow stricter policies than journal editors or reviewers (Cooper
et al. 2006). Also, editors often do not perceive ethical issues as a relevant problem
or important for their work (Wager et al. 2009).
Most of the journals in our study did not have policies on mandatory trial
registration. As a public EU Clinical Trials Register (https://www.clinicaltrials
register.eu/) was launched only in 2011, it may have not been perceived as relevant
by biomedical editors in Europe. Also, most of the countries in our sample did not
have local trial registries established at the time of the study, so the editors may not
have been aware of the registration policy (De Angelis et al. 2004).
Our study has several limitations. Firstly, the search limits were set to include
journals according to the country of publication, journals published in English and
journals currently indexed in MEDLINE. There are currently many more journals in
the regions which are not indexed in MEDLINE, thus our results may not be
generalizable to all journals in the studied regions. Secondly, our analysis was
focused on formal ethical requirements as stated in the journal instructions. It is well
understood that endorsement of ethical requirements in the instructions to authors
does not necessarily mean compliance with them in practice (Meerpohl et al. 2011).
Thus, further research is needed to determine practical implementation and
compliance with the ethical requirements in the region. Finally, the study groups
may not have been fully representative of the EU and non-EU countries, as we
excluded Greece because it was a member of the EU but belongs to the South-East
Europe region. The wide variety of ethics publication policies in journals from
South-East Europe and East EU also raises the question of how these policies and
good publication practice in general can be harmonized across the countries and
journals in this region. Our study suggests that journals may not succeed in this
effort alone, and that action of other stakeholders in publishing is needed, from
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publishers and policy makers to scholarly organizations and professional
associations.
A concerted action of all stakeholders is needed in the near future if the research
and academic community in this European region wants to reach and/or maintain
current international publication standards. The situation is alarming because many
journals, which are respected in their countries and serve as important outlets for
regional research, often lack even basic publishing policies, such as requirements for
ethical conduct of animal research and a clear authorship policy. These policies are
critical to ensure both the ethical conduct of research and publication of the research
results. The journals could take the lead by reviewing their policies and describing
them publicly in their guidelines to authors. This advice is relevant not only for
journals in the SEE countries but generally for all journals, as several studies showed
that instructions to authors do not provide an accurate and transparent description of
the publication policies (Wager 2007, Matarese 2008, Meerpohl et al. 2011). The
policies also need to be available in the public domain, such as on journals’ web-sites,
so that the whole research community, including the journals’ readers and authors,
can stay updated about the ethical requirements for publishing research.
With editors often constrained in their ability to promote publication ethics
policies to control and ensure the best quality of presentation of research results, the
policy makers should play a larger role in ensuring that appropriate legal and
administrative tools are in place, e.g. clear rules of action of a journal or research or
educational institution when there are allegations of inappropriate publication
behavior. Collaboration between journals and research institutions may be important
in this respect, as recently proposed by COPE (Wager and Kleinert 2012).
Finally, authors should also be aware that misconduct and disregard of ethics in
research and publishing have a detrimental impact on the reputation of science in
general by misleading other scientists and wasting time and resources. They should
regard publication ethics not as a simple collection of rules that need to be only
formally addressed but as a central part of the research enterprise.
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Appendix
Document modified by Mindaugas Broga from a checklist from INASP (Interna-
tional Network for the Availability of Scientific Publications): author Pippa Smart,
last updated 1/24/2013 10:31:00 AM and guidelines for ethical publication from
ICMJE, WAME and COPE.
Publication Ethics Policies: Publication Ethics in Selected Countries of Central
and Eastern Europe
How to use the document
• If the journal complies with the policies, tick the box (then count the number of
words for expression of the policies in the Instructions and put the number next
to the tick).
• If the journal does not comply, put a cross in the box.
• If you feel a note is required, write it in the margin.
E.g. Journal X complies with the policies [a] and expresses it in 12 words. Journal X
does not comply with the policies [b].
[a] A statement of the journal’s conformance with international editorial standards 412
[b] General information on the process of evaluating manuscripts, with and a summary of the
peer review process
General information about the journal
i. Date of analysis
ii. Journal title
iii. Country
iv. Journal establishment date
v. Impact factor, indexing in bibliographical databases
vi. Time since it acquired an impact factor
vii. Type of publisher (academic/commercial)
viii. Participation in international publication ethics organizations
ix. Number of words in Instructions to Authors
[!] A clearly labeled section entitled ‘‘Information for Authors’’ (or the equivalent) should contain
the following:
[a] A statement of the journal’s conformance with international editorial standards
[b] General information on the process of evaluating manuscripts, with a summary of the peer
review process
[c] A clear statement of expectations regarding redundant publication (republication, duplicate
publication, self-plagiarism, dual submission, ‘‘salami publishing’’, etc.).
[d] A clear statement on an authorship policy. No-one should be listed as a co-author who has not made a
significant contribution to the work. Authors who do not meet the criteria for authorship should be
listed in an acknowledgments section. Ethical position against ghost or gift-authorship.
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